Please assess the completion status of the following clinical trial:

Trial Title: Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~I- PATIENTS~* men or women~* who have been informed about the study~* and who have provided verbal consent to take part in the study~* able to understand written and spoken French~* with non-resectable metastatic cancer of: the colon, or the rectosigmoid junction or the stomach or bile ducts or rectum or gastrointestinal neuroendocrine tumor or lung (not small-cell cancer) or pancreas~* with a caregiver designated as the principal caregiver (family, friend, neighbour)~* who has consented to the principal caregiver taking part in a qualitative interview~* able to take part in an interview lasting roughly one hour~II- CAREGIVERS~* men or women~* who have been informed about the study~* who have provided verbal consent to take part in the study~* able to understand written and spoken French~* able to follow an interview lasting roughly one hour~III-DOCTORS~* men or women~* who have been informed about the study~* who have provided verbal consent to take part in the study~* specialised in specific organ or oncologist prescriber~Exclusion Criteria:~I- PATIENTS~* under guardianship or ward of court~* with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis, severe mental retardation etc.)~II- CAREGIVERS~* under guardianship or ward of court,~* with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis...),~* with severe mental retardation impairing ability to understand.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Stable patients, early responders to treatment and caregivers (Type: None): None
- Stable patients and intermediate responders and c (Type: None): Stable patients and intermediate responders to treatments and caregivers
- Doctors (Type: None): None
- Patients in therapeutic escape and their caregivers (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).